Heparin-induced Thrombocytopenia Market Report 2032: Epidemiology Data, Therapies, Latest Approvals by DelveInsight
A single therapy, VLX-1005 (Veralox Therapeutics), is being investigated for treating heparin-induced thrombocytopenia. LAS VEGAS, NEVADA, UNITED STATES, March 27, 2024 /EINPresswire.com/ -- DelveInsight’s “Heparin-induced Thrombocytopenia …